Breaking
● GLP-1 trial shows 34% reduction in cardiovascular events over 5 years ● Senolytics drug enters Phase III — first human trial results expected Q1 2027 ● FDA fast-tracks CRISPR base-editing therapy for sickle cell disease ● Longevity biotech index up 12% YTD as institutional capital accelerates ● AI diagnostic platform achieves 97.2% accuracy in early-stage pancreatic cancer detection ● Harvard study links CGM use to 23% lower all-cause mortality in non-diabetics
Impact Health Magazine
Healthcare investment capital markets
Healthcare Investments

Where Capital Meets Longevity

Institutional-grade analysis of the sectors, companies, and trends reshaping the $12 trillion global healthcare economy.

"The convergence of AI, genomics, and longevity science is creating the most significant wealth-creation opportunity in a generation."
— Impact Health Investment Desk
$12T

Global healthcare market by 2030

34%

Biotech index outperformance vs S&P 5Y

$4.2B

Longevity VC deployed in 2025

18%

Avg. IRR — top-quartile health PE funds

Markets
XBISPDR Biotech ETF+2.4%ARKGARK Genomic Revolution+1.8%HLTHCorebridge Health ETF+0.9%VHTVanguard Health Care ETF-0.3%LABDDirexion Daily S&P Biotech-1.2%GNOMGlobal X Genomics ETF+3.1%EDOCGlobal X Telemedicine ETF+1.5%PINKSimplify Health Care ETF+0.7%XBISPDR Biotech ETF+2.4%ARKGARK Genomic Revolution+1.8%HLTHCorebridge Health ETF+0.9%VHTVanguard Health Care ETF-0.3%LABDDirexion Daily S&P Biotech-1.2%GNOMGlobal X Genomics ETF+3.1%EDOCGlobal X Telemedicine ETF+1.5%PINKSimplify Health Care ETF+0.7%
Investment Verticals

Six Sectors. One Thesis.